Tanini Annita sold $13K of KROS
Tanini Annita (Corp. Controller & VP, Finance) sold 1,224 shares of Keros Therapeutics, Inc. (KROS) at $10.29 on 2026-08-18.
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 8:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KROS
Neutral
high confidence
Mentioned
$KROS
Relevance
3/10
Decision brief
The 30-second read
01
Why it matters
The sale is small and unlikely to affect stock price.
02
Market read
Limited relevance; primarily of interest to insiders and compliance monitors.
03
What to watch
No other material news about Keros Therapeutics on this date.
Relevance 3/10Novelty 4/10Timing: filed today
Background
SEC Form 4 filing discloses insider transaction.
Company-level read
Ticker impact
Context
Form 4 shows insider sold 1,224 shares for $12.6K, reducing holdings to 45,144 shares.
Expected impact
No material price impact expected.
Evidence & confidence
The transaction amount is small relative to float and typical insider activity.
Market effects
Sector
None
Regional
None
Global
None
Counterpoint
What could challenge this read
Insider sale could be routine rebalancing, not a red flag.
Key entities
- OfficerTanini Annita
Corp. Controller & VP, Finance of Keros Therapeutics